Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Utopia SIS SpA is an investment company based in Italy, established to invest in high-growth projects within the Life Sciences sector. Founded to address the significant gap in venture capital investments in Italy compared to other European countries, Utopia focuses on startups that contribute to collective well-being across the value chain.
The firm currently manages a portfolio of six companies and primarily invests in Seed and Series A stages. Utopia SIS SpA aims to fill the funding void in Italy's life sciences sector, emphasizing scientific merit and innovative solutions to unmet medical needs.
With a dedicated team and a clear investment strategy, Utopia SIS SpA is positioned to support the growth of pioneering companies in the biotech and healthcare fields.
Utopia SIS SpA invests primarily in Seed and Series A stages within the Life Sciences sector, targeting innovative startups that develop potential therapies for unmet medical needs. Their investment focus includes Disease Modifying Drugs, Medical Devices, Diagnostic Tools and Biomarkers, and Cross-border applications of Artificial Intelligence in healthcare.
The organization seeks projects that demonstrate scientific merit and have the potential to contribute significantly to collective well-being. Utopia SIS SpA emphasizes the importance of innovative solutions that can address pressing healthcare challenges, making it a key player in the European venture capital landscape.
Utopia SIS SpA's portfolio includes six notable companies that are actively contributing to the medical and scientific ecosystem:
These companies are involved in various aspects of the life sciences sector, showcasing high-growth potential and innovative approaches to healthcare challenges.
Antonio Falcone - Chief Executive Officer. Antonio has extensive experience in venture capital and has led numerous investments in the Life Sciences sector.
Sergio Abrignani - Scientific Venture Partner. Sergio brings a wealth of scientific expertise and has been instrumental in evaluating the scientific merit of potential investments.
Rodolfo Quagliuolo - Risk Manager. Rodolfo focuses on assessing the risks associated with investments and ensuring the firm's portfolio remains robust.
Emanuele D'Erme - Financial Analyst. Emanuele provides financial insights and analysis to support investment decisions.
To pitch Utopia SIS SpA, founders should submit their proposals via email to info@utopiasis.it. A comprehensive pitch deck is essential, detailing the startup's vision, market potential, and scientific basis for the proposed solutions.
As of October 2023, Utopia SIS SpA continues to expand its portfolio in the Life Sciences sector, focusing on innovative startups that address unmet medical needs. The firm has recently engaged in discussions with several promising companies in Europe.
Utopia SIS SpA remains committed to filling the venture capital gap in Italy, actively seeking out high-growth projects that align with its investment thesis.
What are Utopia SIS SpA's investment criteria?
Utopia SIS SpA invests in Seed and Series A stages, focusing on innovative projects within the Life Sciences sector that address unmet medical needs.
How can I pitch to Utopia SIS SpA?
Founders can pitch their startups by visiting the Utopia SIS SpA website and using the contact email provided. A detailed pitch deck should be included, highlighting the scientific merit and potential impact of the project.
What makes Utopia SIS SpA different from other investors?
The firm specifically targets the Life Sciences sector in Italy, aiming to fill the venture capital gap in the region and focusing on scientific merit in their investment decisions.
What is the geographic scope of Utopia SIS SpA's investments?
Utopia SIS SpA primarily invests in startups based in Europe, particularly those that are innovating within the Life Sciences sector.
What kind of support can portfolio companies expect?
Utopia SIS SpA provides operational support and strategic guidance to its portfolio companies, helping them navigate the complexities of the healthcare market.
What is the typical check size for investments?
While specific check sizes are not disclosed, Utopia SIS SpA focuses on Seed and Series A investments, which typically range from several hundred thousand to a few million euros.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.